Indication · Neurology & Neurosurgery
Hydrocephalus
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
223
Cleared or approved since 2000
PMA and De Novo
1
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
12
83 device trials in all
Devices
222 devices via 510(k). PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Ps Medical Strata Nsc Lumboperitoneal Valve and Shunt System
Medtronic Neurosurgery · 510(k) · Shunt, Central Nervous System And Components · newest 2009 · 5 decisions
59 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
Rhaeos, Inc.Not on our public-company list
NCT07815314 · 85 participants (planned) · Start Sep 23, 2026 · Primary completion Jan 2027
Device: Rhaeos Shunt Monitoring System (RSMS); ShuntCheck III · For: Hydrocephalus
Sites: Chicago, Illinois; Baltimore, Maryland; Williamsville, New York · 4 sites in all
82 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Shunt, Central Nervous System And Components (JXG)108
- Device, Monitoring, Intracranial Pressure (GWM)56
- Endoscope, Neurological (GWG)45
- Catheter, Ventricular (HCA)7
- Catheter, Ventricular (Containing Antibiotic Or Antimicrobial Agents) (NHC)3
- Cannula, Ventricular (HCD)2
- External Cerebrospinal Fluid (Csf) Diversion (PCB)2
Research
- Device studies on hydrocephalus across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.